Skip to main content
. 2016 Sep 12;2016(9):CD011567. doi: 10.1002/14651858.CD011567.pub2
Study Reason for exclusion
Bakish 1994 Study design (single case).
Baldini Rossi 2000 Participants were not primarily diagnosed with panic disorder.
Balon 1991 Study design (panicogenic).
Balon 1993 Study design (panicogenic).
Bystritsky 1990 Study design (not double‐blind).
Charney 1986 Study design (not randomised).
Davis 1981 Study design (it is not a study).
de Jonghe 1989 Participants were diagnosed with anxiety disorders including panic disorder, but the randomisation was not stratified by diagnosis; wrong comparison (lorazepam versus suriclone).
Dell'Erba 2006 Study design (not randomised); combined therapy with cognitive behaviour therapy.
den Boer 1987 Participants were diagnosed with anxiety disorders including panic disorder, but the randomisation was not stratified by diagnosis.
Dunner 1986 Participants were diagnosed with anxiety disorders including panic disorder, but the randomisation was not stratified by diagnosis.
Dyukova 1992 Study design (not randomised); participants were not diagnosed with panic disorder.
Evans 1986 Combined therapy with psychotherapy.
Fahy 1992 Combined therapy with psychotherapy.
Franulic 1989 Study design (not randomised).
Furukawa 2009 Study design (it is not a study); combined therapy with cognitive behaviour therapy.
Grilo 1998 Combined therapy with cognitive behaviour therapy.
Keller 1993 Participants were not primarily diagnosed with panic disorder.
Lepola 1989 Study design (not randomised).
Mavissakalian 2003 Study design (long‐term phase of a discontinuation/maintenance open‐label study).
McHugh 2007 Combined therapy with cognitive behaviour therapy.
Miretzky 1992 Combined therapy with cognitive behaviour therapy.
Nair 1982 Participants were diagnosed with anxiety disorders including panic disorder, but the randomisation was not stratified by diagnosis.
Nardi 2011 Study design (not double‐blind).
Pareek 2014 Wrong comparison (clonazepam‐CR versus clonazepam).
Pfizer 2002 Wrong comparison (venlafaxine versus placebo).
Pfizer 2005 Study design (not double‐blind).
Pohl 1989 Combined therapy with psychotherapy.
Pollack 2003 Combined therapy with different drugs.
Pyke 1989 Study design (panicogenic).
Raffaele 2002 Wrong comparison (citalopram versus placebo).
Roll 2004 Combined therapy with cognitive behaviour therapy.
Roy‐Byrne 2001 Wrong comparison (paroxetine versus usual care).
Sheehan 1980 Participants were not diagnosed with panic disorder.
Surman 1986 Study design (not randomised).
Svebak 1990 Study design (not randomised).
Tsutsui 2000 Wrong comparison (paroxetine versus placebo).
Tyrer 1988 Participants with different diagnosis, and randomisation was not stratified according to diagnosis.
van Apeldoorn 2008 Combined therapy with cognitive behaviour therapy.
Yang 2005 Study design (not double‐blind).
Yang 2006 Study design (not double‐blind).
Yeragani 1992 Study design (panicogenic).
Zajecka 1996 Participants were not diagnosed with panic disorder.